Target intelligence / Profile preview

No specific drug-like molecular target

Molecular classification
Other
01

Overview

The designation "No specific drug-like molecular target" refers to therapeutic agents that do not exert their effects by binding to a specific biological macromolecule, such as a receptor, enzyme, or ion channel (ChEMBL Database, 2024). Instead, these substances typically act through non-specific physical or chemical processes. For example, antacids like aluminum hydroxide work by directly neutralizing gastric acid, while osmotic laxatives like polyethylene glycol create an osmotic gradient to retain water in the intestinal lumen (Goodman & Gilman's The Pharmacological Basis of Therapeutics). Other examples include activated charcoal, which acts via physical adsorption of toxins in the gastrointestinal tract (StatPearls, 2023). Because these agents lack a specific molecular "lock," they do not follow traditional structure-activity relationship (SAR) models used in drug discovery. This classification is crucial for pharmacological databases to categorize drugs that have clear clinical utility but do not fit the standard target-based paradigm.

Other names
Non-specific targetUnknown targetPhysical mechanism of actionChemical mechanism of action
02

Mechanism of action

Therapeutic effect is achieved through non-specific physical or chemical properties, such as acid neutralization, osmotic pressure changes, or physical adsorption, rather than binding to a specific biological macromolecule (Goodman & Gilman's The Pharmacological Basis of Therapeutics).

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Electrolyte imbalanceInterference with absorption of co-administered drugsNon-specific systemic accumulation
06

Interacting drugs

Magnesium hydroxide

5 more in the full profile.

Beyond the preview

Go deeper on No specific drug-like molecular target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No specific drug-like molecular target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call